Pharmaceuticals, Biotechnology and Life Sciences
Initial phase 1 clinical data demonstrated that subcutaneous administration of RUC-4 resulted in a potent, rapid, and sustained platelet inhibition…
SEATTLE–(BUSINESS WIRE)–Omeros Corporation (Nasdaq: OMER) today announced publication of study results showing that inhibition of mannan-binding lectin-associated serine protease-2 (MASP-2)…
DUBLIN–(BUSINESS WIRE)–The “Respiratory Diseases Drugs Global Market Forecast To 2022” report has been added to ResearchAndMarkets.com’s offering. Where is the…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create…
TAMPA, Fla.–(BUSINESS WIRE)–Oragenics, Inc. (NYSE American: OGEN), a leader in the development of new antibiotics against infectious diseases and effective…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, announced today that it has named Andrew A. Komjathy as…
CHANDLER, Ariz.–(BUSINESS WIRE)–#AZBW–The Arizona Bioindustry Association (AZBio) today announced that Marti Lindsey, PhD, community engagement director for the Southwest Environmental…
Sercader Ltd. Engaged to Identify European Commercial Partner CARLSBAD, Calif.–(BUSINESS WIRE)–$LCTX #AMD—Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX),…
MONTREAL–(BUSINESS WIRE)–Today Inversago Pharma Inc., a preclinical-stage biotech company developing new CB1 blockers for the treatment of targeted metabolic disorders,…
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to developing and commercializing next-generation medicines to improve…